|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12R 1/19 | (2006.01) |
| C12N 15/70 | (2013.01) | ||
| C12N 1/20 | (2006.01) | ||
| C12P 21/02 | (2013.01) | ||
| C12N 9/0051 | (2013.01) | ||
| C12Y 108/01009 | (2013.01) | ||
| C12Y 108/01007 | (2013.01) | ||
| C12Y 503/04001 | (2013.01) | ||
| C12N 9/90 | (2013.01) | ||
| C12N 15/52 | (2013.01) | ||
| C12R2001/19 | (2021.05) | ||
| C12N 1/205 | (2021.05) |
| (11) | Number of the document | 3877552 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19836059.6 |
| Date of filing the European patent application | 2019-11-07 | |
| (97) | Date of publication of the European application | 2021-09-15 |
| (45) | Date of publication and mention of the grant of the patent | 2023-02-22 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2019/060345 |
| Date | 2019-11-07 |
| (87) | Number | WO 2020/097385 |
| Date | 2020-05-14 |
| (30) | Number | Date | Country code |
| 201862757498 P | 2018-11-08 | US |
| (72) |
GROFF, Daniel , US
|
| (73) |
Sutro Biopharma, Inc. ,
111 Oyster Point Blvd, South San Francisco, CA 94080,
US
|
| (54) | E COLI STRAINS HAVING AN OXIDATIVE CYTOPLASM |
| E COLI STRAINS HAVING AN OXIDATIVE CYTOPLASM |